Literature DB >> 18340549

Epidermal growth factor receptors: function modulation by phosphorylation and glycosylation interplay.

Afshan Kaleem1, Ishtiaq Ahmad, Daniel C Hoessli, Evelyne Walker-Nasir, Muhammad Saleem, Abdul Rauf Shakoori.   

Abstract

Post-translational modifications (PTMs) of proteins induce structural and functional changes that are most often transitory and difficult to follow and investigate in vivo. In silico prediction procedures for PTMs are very valuable to foresee and define such transitory changes responsible for the multifunctionality of proteins. Epidermal growth factor receptor (EGFR) is such a multifunctional transmembrane protein with intrinsic tyrosine kinase activity that is regulated primarily by ligand-stimulated transphosphorylation of dimerized receptors. In human EGFR, potential phosphorylation sites on Ser, Thr and Tyr residues including five autophosphorylation sites on Tyr were investigated using in silico procedures. In addition to phosphorylation, O-GlcNAc modifications and interplay between these two modifications was also predicted. The interplay of phosphorylation and O-GlcNAc modification on same or neighboring Ser/Thr residues is termed as Yin Yang hypothesis and the interplay sites are named as Yin Yang sites. Amongst these modification sites, one residue is localized in the juxtamembrane (Thr 654) and two are found in the catalytic domain (Ser 1046/1047) of the EGFR. We propose that, when EGFR is O-GlcNAc modified on Thr 654, EGFR may be transferred from early to late endosomes, whereas when EGFR is O-GlcNAc modified on Ser 1046/1047 desensitization of the receptor may be prevented. These findings suggest a complex interplay between phosphorylation and O-GlcNAc modification resulting in modulation of EGFR's functionality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18340549     DOI: 10.1007/s11033-008-9223-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  44 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.

Authors:  P Burke; K Schooler; H S Wiley
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

4.  Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia.

Authors:  Jia Liu; Yi Pang; Theresa Chang; Pam Bounelis; John C Chatham; Richard B Marchase
Journal:  J Mol Cell Cardiol       Date:  2005-12-09       Impact factor: 5.000

5.  A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities.

Authors:  Kyoko Hida; Michael Klagsbrun
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

6.  Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome.

Authors:  J Bao; I Alroy; H Waterman; E D Schejter; C Brodie; J Gruenberg; Y Yarden
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

7.  Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival.

Authors:  Yi Wang; Steven Pennock; Xinmei Chen; Zhixiang Wang
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669.

Authors:  I C Northwood; F A Gonzalez; M Wartmann; D L Raden; R J Davis
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

9.  Autophosphorylation sites on the epidermal growth factor receptor.

Authors:  J Downward; P Parker; M D Waterfield
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

10.  Immediate-early gene regulation by interplay between different post-translational modifications on human histone H3.

Authors:  Afshan Kaleem; Daniel C Hoessli; Ishtiaq Ahmad; Evelyne Walker-Nasir; Anwar Nasim; Abdul Rauf Shakoori
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

View more
  6 in total

1.  West Nile virus infection induces depletion of IFNAR1 protein levels.

Authors:  Jared D Evans; Rachel A Crown; Ji A Sohn; Christoph Seeger
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

2.  Expression and ultrastructural localization of Mint2 in the spinal cord of rats.

Authors:  Ling-Ling Yao; Xue-Yuan Liu; Ji-Yang Jin; Bei-Bei Tao; Yu-Juan Chen; Yong-Chun Yu; Wei-Hong Bian; Jing Yu; Jing Huang; Yong-Gang Wang
Journal:  Mol Biol Rep       Date:  2010-04-06       Impact factor: 2.316

3.  Glucosamine induces cell death via proteasome inhibition in human ALVA41 prostate cancer cell.

Authors:  Bao-Qin Liu; Xin Meng; Chao Li; Yan-Yan Gao; Ning Li; Xiao-Fang Niu; Yifu Guan; Hua-Qin Wang
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

Review 4.  Altered Mucins (MUC) trafficking in benign and malignant conditions.

Authors:  Suhasini Joshi; Sushil Kumar; Amit Choudhury; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Oncotarget       Date:  2014-09-15

5.  Charge and Polarity Preferences for N-Glycosylation: A Genome-Wide In Silico Study and Its Implications Regarding Constitutive Proliferation and Adhesion of Carcinoma Cells.

Authors:  Muhammad Ramzan Manwar Hussain; Zeeshan Iqbal; Wajahat M Qazi; Daniel C Hoessli
Journal:  Front Oncol       Date:  2018-02-28       Impact factor: 6.244

6.  Activated Protein Kinase C (PKC) Is Persistently Trafficked with Epidermal Growth Factor (EGF) Receptor.

Authors:  Carol A Heckman; Tania Biswas; Douglas M Dimick; Marilyn L Cayer
Journal:  Biomolecules       Date:  2020-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.